Mammographic and Clinical Predictors of Drainage Patterns in Breast Lymphoscintigrams Obtained during Sentinel Node Procedures

Clinical Nuclear Medicine

Volumn 28, Issue 7, 2003, Pages 558-564

  Lamonica, Dominick ^a   Edge, Stephen B ^a   Hurd, Thelma ^a   Proulx, Gary ^a   Stomper, Paul C ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Breast Carcinoma; Lymphoscintigraphy; Mammography; Sentinel Lymph Node

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST AREOLA; BREAST CALCIFICATION; BREAST CARCINOMA; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; INTERNAL MAMMARY LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PARENCHYMA; PERITUMORAL DRUG ADMINISTRATION; RELATIVE DENSITY; SCINTIMAMMOGRAPHY; SENTINEL LYMPH NODE; SOFT TISSUE; TUMOR; TUMOR LOCALIZATION; ADOLESCENT; AXILLA; BREAST TUMOR; CLINICAL TRIAL; FEMALE; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SINGLE-BLIND METHOD; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0141610932     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200307000-00005     Document Type: Article

References (24)

1. Alazraki NP, Styblo T, Grant SF, et al: Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma probe. Radiol Clin North Am 39:947, 2001.
2. Dupont EL, Kamath VJ, Ramnath EM, et al: The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol 8:354, 2001.
3. Tuthill LL, Reynolds HE, Goulet RJ: Biopsy of sentinel lymph nodes guided by lymphoscintigraphic mapping in patient with breast cancer. AJR Am J Roentgenol 176:407, 2001.
4. Barnwell JM, Arredondo M, Kollmorgen D, et al: Sentinel node biopsy in breast cancer. Ann Surg Oncol 5:126, 1998.
5. Kopans DB, Lindfors KK, McCarthy KA, et al: Spring hookwire breast lesion localizer: use with rigid-compression mammographic systems. Radiology 157:537, 1985.
6. Page DL, Winfield AC: The dense mammogram. AJR Am J Roentgenol 147:487, 1986.
7. Stomper PC, D'Souza DJ, DiNitto PA, et al: Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol 167:1261, 1996.
8. Mansoor S, Ip C, Stomper PC: Yield of terminal duct lobule units in normal breast stereotactic core biopsy specimens: implications for biomarker studies. Breast Journal 6:220, 2000.
9. Martin RC, Derossis AM, Fey J, et al: Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 130:432, 2001.
10. Nathanson SD, Wachna L, Gilman D, et al: Pathways of lymphatic drainage from the breast. Ann Surg Oncol 6:837, 2001.
11. Shen P, Glass EC, DiFronzo LA, et al: Dermal versus intraparenchymal lymphoscintigraphy of the breast. Ann Surg Oncol 8:241, 2001.
12. Birdwell RL, Smith KL, Betts BJ, et al: Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology 220:47, 2001.
13. Krausz Y, Ikeda DM, Jadvar H, et al: Non-visualization of sentinel lymph node in patients with breast cancer. Nucl Med Commun 22:25, 2001.
14. Eary JF, Mankoff D, Dunnwald LK, et al: Sentinel lymph node mapping for breast cancer: analysis in a diverse patient group. Radiology 213:526, 1999.
15. Byrd DR, Dunwald LK, Mankoff DA, et al: Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol 8:234, 2001.
16. Jansen L, Doting MH, Rutgers EJ, et al: Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 87:920, 2000.
17. van der Ent FW, Kengen RA, van der Pol HA, et al: Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 25:24, 1999.
18. Uren RF, Howman-Giles RB, Thompson JF, et al: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36:1775, 1995.
19. Sugg SL, Ferguson DJ, Posner MC, et al: Should internal mammary nodes be sampled in the senitnel lymph node era? Ann Surg Oncol 7:188, 2000.
20. Klauber-DeMore N, Bevilacqua LB, Van Zee KJ, et al: Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg 195:547, 2001.
21. Overgaard M, Hansen PS, Overgaard P, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 2b Trial. N Engl J Med 337:949, 1997.
22. Rajaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956, 1997.
23. Bentel G, Marks LB, Hardenbergh P, et al: Variability of the location of internal mammary vessels and glandular breast tissue in breast cancer patients undergoing routine CT-based treatment planning. Int J Rad Oncol Bio Phys 44:1017, 1999.
24. Proulx G, Lee RJ, Stomper P: Internal mammary lymph node inclusion in the standard tangent breast fields: effect of body habitus. Breast Journal 7:111, 2001.